Vitamin B6 Side Effects

Reported Vitamin B6 side effects

B6 at RDA-range dietary doses is extremely safe, but the side effect profile at chronic pharmacologic doses is more concerning than most water-soluble vitamins. The hallmark toxicity is a distinctive sensory peripheral neuropathy or sensory ganglionopathy described by Schaumburg in 1983 in patients taking multi-gram pyridoxine doses for years, characterized by burning dysesthesias in the feet, gait unsteadiness, positive sensory symptoms, and in severe cases reduced proprioception with pseudoathetoid movements of outstretched hands — a picture suggesting dorsal root ganglion damage rather than typical distal dying-back neuropathy. Subsequent case series documented the syndrome at sustained doses as low as 200–500 mg/day over months to years, and modern analyses continue to show neuropathy cases at chronic doses above the 100 mg/day UL. The practical implication is that "therapeutic" high-dose B6 (above 100 mg/day) should have a specific clinical indication — NVP with doxylamine, homocystinuria, PDE, PMS at max 100 mg, isoniazid prophylaxis at 25–50 mg — and should not be continued indefinitely without attention to sensory symptoms. Patients on chronic B6 above 200 mg/day should be periodically assessed for early neuropathic symptoms (tingling, burning, unsteadiness) and dose reduced or stopped at first signs. The neuropathy may not fully reverse after stopping high-dose B6, though most patients have partial recovery over months. Beyond neuropathy, acute high-dose B6 can cause photosensitivity skin reactions, GI upset, and rarely anaphylactoid reactions. Pyridoxine's interaction with levodopa is historically famous: pharmacologic B6 enhances peripheral decarboxylation of levodopa (via AADC) and reduces the fraction reaching the CNS, worsening Parkinson disease symptoms in patients on levodopa without carbidopa. Modern Parkinson regimens with carbidopa or benserazide peripherally inhibit AADC and largely eliminate this interaction, so the "avoid B6 in Parkinson disease" rule is outdated for patients on modern combination levodopa; it remains relevant if someone is somehow on pure levodopa. Pyridoxine reduces phenytoin levels and can compromise seizure control — coordinate with neurology if both are needed. Pyridoxine interferes with phenobarbital. Pyridoxine supplementation with isoniazid is protective, not a concern. Pyridoxine with penicillamine (chelator used in Wilson disease, rheumatoid arthritis) is actually complementary, since penicillamine can cause B6 deficiency. Pyridoxine with theophylline is protective — theophylline inhibits pyridoxal kinase and depletes functional B6. Pyridoxine reduces the efficacy of altretamine (chemotherapy), so should be avoided during that treatment. Pyridoxine can interact with alcohol in increasing hepatic clearance of benzodiazepines. GI side effects (nausea, abdominal discomfort, constipation) can occur with high-dose pyridoxine especially on empty stomach. Photosensitive skin reactions have been reported. Rarely, injection-site reactions with IV pyridoxine. Pregnancy: RDA-range B6 is safe; pyridoxine-doxylamine (Diclegis) is ACOG first-line for NVP with excellent safety data over decades of use. Breastfeeding: B6 transfers to breast milk; RDA-range maternal intake supports infant needs, and very high-dose maternal pyridoxine (above 200 mg/day) has been associated with suppression of lactation in some reports — generally avoid high-dose B6 in breastfeeding mothers unless specifically indicated. Pediatric: RDA-range and pediatrician-directed; high-dose pyridoxine for PDE or other indications is pediatric neurology or metabolic medicine territory. The cleanest safety summary: RDA-range B6 is extremely safe; NVP pyridoxine-doxylamine doses are well-tolerated and safe in pregnancy; chronic supplementation above 100 mg/day requires a specific clinical indication and monitoring for sensory neuropathy; doses above 500 mg/day should only be used in specialist-directed protocols for PDE, homocystinuria, or sideroblastic anemia.

When to continue, reduce, or stop Vitamin B6

Vitamin B6 contraindications

B6 is generally very safe at RDA-range dosing but warrants caution in several contexts. Chronic high-dose pyridoxine above 100 mg/day (the tolerable upper limit) is a relative contraindication for general use — the sensory peripheral neuropathy / ganglionopathy syndrome described by Schaumburg 1983 can develop at chronic doses above 200 mg/day with insidious onset and variable reversibility, and doses above the UL should have a specific clinical indication. Patients on chronic B6 for PMS, CTS, or other indications should stop or reduce dose at any sensory symptoms and should avoid long-term multi-year supplementation above 100 mg/day without specialist oversight. Pregnancy: RDA-range B6 and pyridoxine-doxylamine at NVP treatment doses (up to 40 mg pyridoxine/day total) are safe with decades of safety data. Very high-dose B6 in pregnancy outside specific metabolic indications is not studied and should be avoided. Breastfeeding: RDA-range B6 is safe; very high-dose maternal pyridoxine (above 200 mg/day) has been reported to suppress lactation in some case reports, and high-dose B6 should be avoided in breastfeeding mothers unless specifically indicated. Pediatric: RDA-range B6 is safe; high-dose pyridoxine for PDE is pediatric neurology territory with careful dose titration; inadvertent high-dose B6 from adult multivitamin exposure is a concern for infants and young children and warrants storage safety. Parkinson disease on pure levodopa (without carbidopa): B6 accelerates peripheral decarboxylation and reduces CNS levodopa delivery — this is historical and mostly irrelevant now given universal use of carbidopa-levodopa or benserazide-levodopa combinations, but pure levodopa patients (rarely encountered) should avoid pharmacologic B6. Modern combination levodopa patients can safely take RDA-range B6. Phenytoin therapy: pharmacologic B6 lowers phenytoin levels and can compromise seizure control; coordinate with neurology if both are needed. Phenobarbital levels also can drop with pharmacologic B6. Altretamine (hexamethylmelamine) chemotherapy: B6 reduces efficacy and is contraindicated during treatment. True allergic reactions to pyridoxine are rare. Renal disease on hemodialysis: B6 losses in dialysate warrant supplementation typically 5–10 mg/day, and patients should be on appropriate replacement dose. Celiac disease, inflammatory bowel disease, bariatric surgery: B6 absorption may be impaired and supplementation may be needed. Alcoholism: chronic heavy alcohol use impairs B6 metabolism; B6 supplementation is standard in alcohol-related nutritional rehabilitation alongside thiamine, folate, and B12. Isoniazid therapy: pyridoxine 25–50 mg/day is protective, not contraindicated — this is standard prophylaxis to prevent INH neuropathy. Theophylline therapy: B6 supplementation is reasonable given theophylline's inhibition of pyridoxal kinase. Penicillamine therapy (Wilson disease, RA): penicillamine depletes B6 via Schiff base formation with pyridoxal; supplementation is indicated. Levodopa without carbidopa (rare): contraindicated at pharmacologic doses. Drug interactions warranting attention: isoniazid (protective), theophylline (protective), penicillamine (protective), phenytoin (dose coordination), phenobarbital (dose coordination), altretamine (avoid during chemo), levodopa without carbidopa (avoid pharmacologic B6), oral contraceptives (modest B6 depletion). Overall B6 is very safe at RDA-range, moderate safety profile at NVP treatment doses, and warrants monitoring at chronic doses above 100 mg/day with clear stopping rules at any sensory symptoms. This is general educational content, not medical advice.

Why vendor quality drives Vitamin B6 side-effect frequency

Research-compound communities consistently report that adverse-event frequency tracks with source quality. Three reasons: (1) impurity profiles vary by lab (residual synthesis byproducts can trigger reactions); (2) mislabeled mass means actual dose can be 50-150% of stated dose; (3) reconstitution-grade water and capping methodology affect long-term storage stability. COA-verified vendors with published HPLC data minimize all three failure modes. Check a vendor's COA record and Trust Score before you buy.

Vitamin B6 side effects FAQ

Research-use disclaimer. All safety information on this page summarizes published research literature and community-reported reactions. It is not medical advice and not authorization for human consumption. Always consult a licensed practitioner before any compound enters a clinical context. Compounds linked from this page are sold for research-use only.
Affiliate disclosure. See our affiliate disclosure .